Fish by-products yield collagen peptides with clinically demonstrated benefits for skin hydration, wrinkle reduction, and joint pain, plus blood pressure-lowering potential, while supporting environmental sustainability.
10 g/day for 8-12 weeksClinical trials demonstrate that daily fish collagen peptide supplementation at this dose improves skin hydration, elasticity, wrinkle reduction, and osteoarthritis joint pain
What the researchers found
Fish scales and bones contain 30-40% organic collagen matrix and 60-70% hydroxyapatite. Modern extraction methods achieve collagen yields of 25-35%, with ultrasound and microwave-assisted techniques reducing processing from days to minutes while preserving bioactivity.
Key health findings include: antioxidant capacities comparable to or exceeding vitamins C and E; ACE-inhibitory peptides lowering blood pressure in preclinical models; and clinical trial evidence that 10 g daily fish collagen peptide supplementation for 8-12 weeks improves skin hydration, elasticity, wrinkle reduction, and reduces osteoarthritis-related joint pain. Nanocarrier delivery systems (nanoliposomes, nanoemulsions) enhance bioavailability and stability.
Why it matters
The seafood industry generates enormous amounts of fish waste. Converting this waste into health-promoting collagen peptides creates a sustainable, circular economy while providing consumers with clinically validated supplements for skin aging and joint health. This approach addresses both environmental waste and human health needs simultaneously.
How the study worked
This is a comprehensive review synthesizing evidence from extraction science, preclinical studies, and clinical trials on collagen and bioactive peptides derived from fish scales and bones. It covers extraction methods, peptide bioactivities, delivery technologies, and sustainability considerations.
What this study cannot tell us
As a review, this paper synthesizes existing evidence rather than generating new data. While clinical trial results for skin and joint benefits are cited, the specific trial details (sample sizes, controls) are not elaborated. ACE-inhibitory effects remain preclinical. Standardization of peptide products across different fish species and extraction methods remains a challenge. Regulatory frameworks vary by country.
How to read the evidence
This review draws on a mix of evidence: clinical trial data for skin and joint benefits, preclinical data for blood pressure and antioxidant effects, and technical data for extraction methods. The clinical evidence is the strongest component, while some health claims remain at the preclinical stage.
When this study was published
Published in 2025, this review incorporates the latest advances in extraction technology, nanocarrier delivery, and clinical evidence for marine collagen peptides.
The bigger picture
Marine collagen peptides are part of the rapidly growing 'blue bioeconomy' — turning ocean resources and by-products into valuable health products. As consumers increasingly seek sustainable, science-backed supplements, fish-derived collagen peptides are positioned at the intersection of environmental responsibility and evidence-based nutrition, with the added appeal of being naturally sourced.
Questions still open
- How do fish collagen peptides compare to bovine or porcine collagen in clinical efficacy for skin and joint health?
- Can ACE-inhibitory peptides from fish collagen actually lower blood pressure in humans, not just preclinical models?
- What is the optimal molecular weight range for fish collagen peptides to maximize oral bioavailability and specific health effects?
Common questions
Are fish collagen peptides as good as other types of collagen supplements?
How long does it take for fish collagen supplements to work?
Read the original research
Valorisation of fish scales and bones: a sustainable source of bioactive proteins and collagen for nutraceuticals.
Bioresources and bioprocessing, 12(1), 141
Citation
Jeyachandran, Sivakamavalli; Aman, Mohammed. (2025). Valorisation of fish scales and bones: a sustainable source of bioactive proteins and collagen for nutraceuticals.. Bioresources and bioprocessing, 12(1), 141. https://doi.org/10.1186/s40643-025-00970-w